Due to these advancements in genetic testing, the number of atypical, often milder phenotypes described is rapidly increasing especially in NCL forms where a lysosomal enzyme is affected such as CLN2 disease (8–10). Here, TPP1 is linked to neuronal ceroid lipofuscinosis.